These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18815923)

  • 21. [Non-invasive molecular detection of bladder cancer].
    Hatachmi S
    Harefuah; 2009 Jan; 148(1):66-9, 86. PubMed ID: 19320394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editorial comment.
    Menendez V
    Urology; 2010 Feb; 75(2):355; author reply 355-6. PubMed ID: 20152484
    [No Abstract]   [Full Text] [Related]  

  • 23. Is it time for a new bladder neoplasms classification?
    Morichetti D; Giorgini S; Pieramici T; Barbisan F; Mazzucchelli R
    Anal Quant Cytol Histol; 2008 Dec; 30(6):338-40. PubMed ID: 19160700
    [No Abstract]   [Full Text] [Related]  

  • 24. Proliferative urocystica and adenoma in a guinea-pig.
    Somvanshi R; Sharma VK
    J Comp Pathol; 2005 Nov; 133(4):277-80. PubMed ID: 16154139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continous improvement of TNM staging system for bladder cancer.
    Ward JF; Margulis V
    Cancer; 2009 Feb; 115(4):704-5. PubMed ID: 19117038
    [No Abstract]   [Full Text] [Related]  

  • 26. Four-leafed clover.
    Kanomata N
    Int J Surg Pathol; 2009 Feb; 17(1):41. PubMed ID: 18480389
    [No Abstract]   [Full Text] [Related]  

  • 27. A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma.
    Wang YH; Yeh SD; Shen KH; Shen CH; Juang GD; Hsu LI; Chiou HY; Chen CJ
    Toxicol Appl Pharmacol; 2009 Nov; 241(1):111-8. PubMed ID: 19686770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Epidemiology and pathogenesis of bladder cancer].
    Adolphs HD; Thiele J; Vahlensieck W
    Onkologie; 1980 Oct; 3(5):214-24. PubMed ID: 7005781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bladder cancer and smoking. Part 1: addressing the associated risk factors.
    Anderson B; Naish W
    Br J Nurs; 2008 Oct 9-22; 17(18):1182-6. PubMed ID: 18946399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary urothelial carcinoma of the upper tract: important clinicopathological factors predicting bladder recurrence after surgical resection.
    Huang WW; Huang HY; Liao AC; Shiue YL; Tai HL; Lin CM; Wang YH; Lin CN; Shen KH; Li CF
    Pathol Int; 2009 Sep; 59(9):642-9. PubMed ID: 19712132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classification of bladder cancer.
    Andersson L
    Prog Clin Biol Res; 1984; 162A():27-32. PubMed ID: 6483911
    [No Abstract]   [Full Text] [Related]  

  • 32. Optimal timing of radical cystectomy for patients with T1 bladder cancer.
    Bochner BH
    Urol Oncol; 2009; 27(3):329-31. PubMed ID: 19414124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alcohol, coffee, and bladder cancer risk: a review of epidemiological studies.
    Pelucchi C; La Vecchia C
    Eur J Cancer Prev; 2009 Feb; 18(1):62-8. PubMed ID: 19077567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic biomarkers in urothelial bladder cancer.
    Kim WJ; Kim YJ
    Expert Rev Mol Diagn; 2009 Apr; 9(3):259-69. PubMed ID: 19379084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Friend or foe? Role of peroxisome proliferator-activated receptor-gamma in human bladder cancer.
    Inamoto T; Shah JB; Kamat AM
    Urol Oncol; 2009; 27(6):585-91. PubMed ID: 19162510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics.
    Shanks JH; Iczkowski KA
    Histopathology; 2009 Jun; 54(7):885-900. PubMed ID: 19178589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bladder cancer today.
    Sternberg CN; Lerner SP; Fitzpatrick JM
    BJU Int; 2008 Nov; 102(9 Pt B):1203. PubMed ID: 19035882
    [No Abstract]   [Full Text] [Related]  

  • 38. Arsenic methylation capability, myeloperoxidase and sulfotransferase genetic polymorphisms, and the stage and grade of urothelial carcinoma.
    Huang SK; Chiu AW; Pu YS; Huang YK; Chung CJ; Tsai HJ; Yang MH; Chen CJ; Hsueh YM
    Urol Int; 2009; 82(2):227-34. PubMed ID: 19322015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Carcinosarcoma of the urinary bladder. Report of three cases].
    Haj Salah MB; Mekni A; Nouira Y; Haha-Bellil SB; Bellil K; Kchir N; Haouet S; Horchani A; Zitouna M
    Tunis Med; 2007 Nov; 85(11):982-4. PubMed ID: 19166155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cancer of the urinary bladder].
    Sorensen BL
    Nord Med; 1967 Apr; 77(15):461-8. PubMed ID: 6022649
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.